Velan Capital Investment Management as of Sept. 30, 2024
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 18 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Jasper Therapeutics Com New (JSPR) | 25.2 | $27M | 1.4M | 18.81 | |
| Praxis Precision Medicines I Com New (PRAX) | 18.9 | $20M | 351k | 57.54 | |
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 13.9 | $15M | 150k | 98.80 | |
| Heron Therapeutics (HRTX) | 13.0 | $14M | 7.0M | 1.99 | |
| Tourmaline Bio (TRML) | 8.0 | $8.5M | 331k | 25.71 | |
| Rezolute Com New (RZLT) | 3.6 | $3.9M | 800k | 4.85 | |
| Liquidia Corporation Com New (LQDA) | 2.8 | $3.0M | 300k | 10.00 | |
| Context Therapeutics (CNTX) | 2.4 | $2.5M | 1.3M | 1.96 | |
| Inspiremd (NSPR) | 2.3 | $2.4M | 904k | 2.68 | |
| Scpharmaceuticals (SCPH) | 2.2 | $2.4M | 518k | 4.56 | |
| Tela Bio (TELA) | 1.8 | $1.9M | 747k | 2.53 | |
| Optinose | 1.3 | $1.4M | 2.1M | 0.67 | |
| Zevra Therapeutics Com New (ZVRA) | 1.3 | $1.4M | 200k | 6.94 | |
| Protara Therapeutics Com Stk (TARA) | 1.0 | $1.1M | 574k | 1.83 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.0 | $1.0M | 50k | 20.63 | |
| Skye Bioscience Com New (SKYE) | 0.8 | $825k | 211k | 3.91 | |
| Kiora Pharmaceuticals (KPRX) | 0.4 | $447k | 122k | 3.66 | |
| Tenax Therapeutics Com New (TENX) | 0.3 | $288k | 83k | 3.46 |
